Skip to content

What's New — Elbow — June 2026

8 new articles published this month.

Themes: Total Elbow Arthroplasty Outcomes · Pediatric and Overuse Elbow Injuries · Soft Tissue and Joint Pathology Concepts · Medical Technology and Methodology

Digest generated 2026-07-04 16:15:06+00:00.

Highlights

Total Elbow Arthroplasty Outcomes

Recent literature focuses on optimizing outcomes and diagnosis in total elbow arthroplasty (TEA). Nieboer et al. [2] establish specific synovial fluid leukocyte and neutrophil cutoff values to improve the diagnosis of periprosthetic joint infection, addressing the lack of elbow-specific data. Rudisill et al. [3] evaluate the impact of prior olecranon osteotomy on subsequent TEA, finding that while operative considerations differ, implant survivorship remains acceptable. These studies collectively enhance the management of complex elbow revisions and infection diagnostics, providing surgeons with evidence-based thresholds and prognostic insights for TEA procedures.

Pediatric and Overuse Elbow Injuries

This theme addresses elbow pathology in young athletes, specifically focusing on risk factors and management. Kamiya et al. [8] identify thirty-six months of competitive play and thirty degrees of hip internal rotation as critical thresholds for capitellar osteochondritis dissecans in youth baseball players, offering preventive insights. Manzi et al. [5] further explore biomechanical risks in professional pitchers, demonstrating that early trunk rotation increases elbow distractive forces despite equivalent ball velocity. Together, these articles highlight the importance of biomechanical analysis and duration of play in preventing overuse injuries across different levels of athletic competition.

Soft Tissue and Joint Pathology Concepts

Articles in this cluster cover diverse soft tissue and joint conditions, ranging from conservative management to surgical reconstruction. Coliva et al. [6] present a case series supporting conservative treatment for distal biceps tendon ruptures, challenging the surgical norm with long-term follow-up data. Marinelli et al. [4] provide current concepts for acute and chronic proximal radio-ulnar joint injuries, outlining diagnostic and treatment frameworks. Additionally, Jerome et al. [7] systematically review upper limb reconstruction in arthrogryposis multiplex congenita, synthesizing nonsurgical and surgical strategies. These studies expand the therapeutic armamentarium for both traumatic and congenital upper limb disorders.

Medical Technology and Methodology

This theme encompasses methodological critiques and the integration of technology in orthopaedic research. Khurana and Kumar [1] offer a methodological consideration regarding the use of ChatGPT for patient education, emphasizing that AI should supplement rather than replace clinical expertise. While distinct from clinical interventions, this article reflects the growing intersection of artificial intelligence and medical communication. It stands apart from the clinical treatment studies, focusing instead on the reliability and reporting standards of emerging digital health tools in the context of elbow pathology information dissemination.

Articles by Theme

Total Elbow Arthroplasty Outcomes (2)

2. Nieboer M, Rosenow C, Koch J, et al. Morrey Award 2025: Cell Count and Differential of Aspirated Fluid in the Diagnosis of Periprosthetic Joint Infection of Total Elbow Arthroplasty. Journal of Shoulder and Elbow Surgery 2026. doi:10.1016/j.jse.2026.05.018

This study determined optimal cutoff values for synovial fluid leukocyte counts, neutrophil percentages, ESR, and CRP to diagnose periprosthetic joint infection following total elbow arthroplasty. Using ROC curve analysis on revision surgery data, the authors established specific diagnostic thresholds tailored to the elbow's unique microbiome. These findings provide essential diagnostic criteria to improve the detection of elbow PJI, addressing a current gap in clinical guidelines.

3. Rudisill SS, You DZ, Fossum BW, et al. How Does a Prior Olecranon Osteotomy Impact the Outcome of Subsequent Total Elbow Arthroplasty?. Journal of Shoulder and Elbow Surgery 2026. doi:10.1016/j.jse.2026.05.020

The study evaluated outcomes and implant survivorship of total elbow arthroplasty in patients with a history of prior olecranon osteotomy for distal humerus fractures. Results indicated that while operative considerations differ, TEA remains a viable option with acceptable survivorship despite the complexity of prior surgery. This suggests that prior olecranon osteotomy should not preclude TEA, though surgeons must anticipate specific technical challenges.

Pediatric and Overuse Elbow Injuries (2)

5. Manzi J, Dillon M, Dowling B, et al. Propensity Matched Professional Baseball Pitchers With Early Trunk Rotation Demonstrate Increased Shoulder and Elbow Distractive Forces with Equivalent Ball Velocity.. Journal of Shoulder and Elbow Surgery 2026. doi:10.1016/j.jse.2026.05.042

Propensity-matched analysis of professional baseball pitchers revealed that early trunk rotation increases shoulder and elbow distractive forces without altering ball velocity. This biomechanical alteration suggests a higher risk of soft tissue injury despite equivalent performance metrics. The findings imply that early trunk rotation is a significant risk factor for upper extremity injuries in pitching mechanics.

8. Kamiya T, Nagasawa M, Oota T, et al. Thirty-Six Months of Experience and 30° of Hip Internal Rotation as Critical Thresholds for Capitellar Osteochondritis Dissecans in Youth Baseball Players. Journal of Shoulder and Elbow Surgery 2026. doi:10.1016/j.jse.2026.06.006

The study identified thirty-six months of competitive play duration and 30° of hip internal rotation as critical risk factors for capitellar osteochondritis dissecans in youth baseball players. Multivariable analysis established these thresholds as independent predictors for the condition. These findings offer specific screening criteria to identify high-risk players and potentially guide preventive interventions in youth sports.

Soft Tissue and Joint Pathology Concepts (3)

4. Marinelli A, Riva M, Di Gennaro GL, et al. Acute and chronic proximal radio-ulnar joint injuries (PRUJ): current concepts. Journal of ISAKOS 2026. doi:10.1016/j.jisako.2026.101159

This article provides a comprehensive review of current concepts regarding the diagnosis and management of acute and chronic proximal radio-ulnar joint injuries. It synthesizes existing literature to outline treatment algorithms and highlight key clinical considerations for both injury types. The review serves as a practical guide for clinicians managing these complex elbow injuries to optimize functional outcomes.

6. Coliva F, Marinelli A, Riva M, et al. Is there still room for conservative treatment of Distal Biceps Tendon ruptures? What patients (and surgeons) should know. A case series with a mean 4-years follow-up. Journal of Shoulder and Elbow Surgery 2026. doi:10.1016/j.jse.2026.05.041

This case series with a mean four-year follow-up evaluates the functional outcomes of conservative treatment for distal biceps tendon ruptures. The results demonstrate that non-operative management can yield satisfactory long-term function in selected patients, challenging the assumption that surgical repair is always superior. These findings support considering conservative treatment as a viable option for specific patient populations and surgeons.

7. Jose Jerome JT, Surendran G, Thirumagal K. Upper Limb Reconstruction in Arthrogryposis Multiplex Congenita: A Systematic Review. The Journal of Hand Surgery 2026. doi:10.1016/j.jhsa.2026.05.010

A systematic review synthesized evidence on nonsurgical and surgical strategies for upper limb reconstruction in arthrogryposis multiplex congenita to develop an evidence-informed treatment algorithm. The analysis of 32 studies involving 412 patients identified key interventions and outcomes across the shoulder, elbow, forearm, wrist, and thumb. This review provides a structured framework to guide clinical decision-making and improve functional outcomes in this complex population.

Medical Technology and Methodology (1)

1. Khurana R, Kumar A. Methodological considerations on—A supplement, not a substitute: Accuracy and completeness of ChatGPT responses for common elbow pathology”. Shoulder & Elbow 2026. doi:10.1177/17585732261457815

The authors critique a study on ChatGPT's accuracy for elbow pathology, noting that the lack of an explicitly stated study design reduces transparency and hinders critical appraisal. They emphasize the need for clear methodological reporting in AI-based medical research to ensure validity. This highlights the importance of rigorous study design documentation when evaluating artificial intelligence tools in clinical contexts.

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International

Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees

Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.